NASDAQ:ZGNX - Zogenix News Headlines

Sign in or create an account to add this stock to your watchlist.
$42.55 -1.06 (-2.43 %)
(As of 12/9/2018 04:00 PM ET)
Previous Close$42.55
Today's Range$42.51 - $44.40
52-Week Range$33.42 - $62.75
Volume553,209 shs
Average Volume535,623 shs
Market Capitalization$1.79 billion
P/E Ratio-10.58
Dividend YieldN/A
Beta1.84

Headlines

Zogenix (NASDAQ ZGNX) News Headlines

Source:
DateHeadline
Leerink Swann Comments on Zogenix, Inc.s FY2021 Earnings (ZGNX)Leerink Swann Comments on Zogenix, Inc.'s FY2021 Earnings (ZGNX)
www.americanbankingnews.com - December 7 at 7:01 AM
Final trades: Home Depot, Target, Charter Communications,...Final trades: Home Depot, Target, Charter Communications,...
finance.yahoo.com - December 6 at 5:08 PM
Zogenix (ZGNX) Given "Buy" Rating at MizuhoZogenix (ZGNX) Given "Buy" Rating at Mizuho
www.americanbankingnews.com - December 6 at 1:01 PM
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - NasdaqZogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Nasdaq
www.nasdaq.com - December 5 at 4:59 PM
Zogenix (ZGNX) Announces Positive Phase 3 Trial Results on Efficacy and Safety of FINTEPLA in Dravet SyndromeZogenix (ZGNX) Announces Positive Phase 3 Trial Results on Efficacy and Safety of FINTEPLA in Dravet Syndrome
www.streetinsider.com - December 4 at 8:53 AM
What Kind Of Share Price Volatility Should You Expect For Zogenix Inc (NASDAQ:ZGNX)?What Kind Of Share Price Volatility Should You Expect For Zogenix Inc (NASDAQ:ZGNX)?
finance.yahoo.com - December 4 at 8:53 AM
Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA® (ZX008) in Dravet SyndromeZogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA® (ZX008) in Dravet Syndrome
globenewswire.com - December 3 at 4:56 PM
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOsThe Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs
feeds.benzinga.com - December 2 at 6:13 PM
Zogenix Presents Positive Findings on the Impact of Treatment with FINTEPLA® (ZX008) on Everyday Executive Function in Patients with Dravet SyndromeZogenix Presents Positive Findings on the Impact of Treatment with FINTEPLA® (ZX008) on Everyday Executive Function in Patients with Dravet Syndrome
finance.yahoo.com - December 2 at 5:18 PM
Zogenix, Inc. (ZGNX) Receives Average Recommendation of "Buy" from AnalystsZogenix, Inc. (ZGNX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 1 at 5:25 AM
Zogenix to Host Investor Update Lunch on FINTEPLA® at the American Epilepsy Society 2018 Annual MeetingZogenix to Host Investor Update Lunch on FINTEPLA® at the American Epilepsy Society 2018 Annual Meeting
finance.yahoo.com - November 29 at 9:07 AM
Zogenix to Participate in the Global Mizuho Investor Conference 2018Zogenix to Participate in the Global Mizuho Investor Conference 2018
finance.yahoo.com - November 27 at 9:09 AM
Erle T. Mast Sells 1,468 Shares of Zogenix, Inc. (ZGNX) StockErle T. Mast Sells 1,468 Shares of Zogenix, Inc. (ZGNX) Stock
www.americanbankingnews.com - November 26 at 10:34 PM
Zogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting - GlobeNewswireZogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting - GlobeNewswire
www.globenewswire.com - November 26 at 5:01 PM
Zogenix to Announce New Data at 72nd American Epilepsy Society Annual MeetingZogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting
finance.yahoo.com - November 26 at 8:43 AM
 Brokerages Expect Zogenix, Inc. (ZGNX) Will Post Earnings of -$1.00 Per Share Brokerages Expect Zogenix, Inc. (ZGNX) Will Post Earnings of -$1.00 Per Share
www.americanbankingnews.com - November 26 at 1:32 AM
Zogenix Is Eyeing Another Indication For ZX008Zogenix Is Eyeing Another Indication For ZX008
seekingalpha.com - November 24 at 8:36 AM
Brokers Set Expectations for Zogenix, Inc.s FY2018 Earnings (ZGNX)Brokers Set Expectations for Zogenix, Inc.'s FY2018 Earnings (ZGNX)
www.americanbankingnews.com - November 15 at 8:46 AM
Form 10-Q ZOGENIX, INC. For: Sep 30Form 10-Q ZOGENIX, INC. For: Sep 30
www.streetinsider.com - November 10 at 5:12 PM
Zogenix Inc. (ZGNX) CEO Stephen Farr on Q3 2018 Results - Earnings Call TranscriptZogenix Inc. (ZGNX) CEO Stephen Farr on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 8:52 AM
Zogenix: 3Q Earnings SnapshotZogenix: 3Q Earnings Snapshot
finance.yahoo.com - November 9 at 8:52 AM
Edited Transcript of ZGNX earnings conference call or presentation 8-Nov-18 9:30pm GMTEdited Transcript of ZGNX earnings conference call or presentation 8-Nov-18 9:30pm GMT
finance.yahoo.com - November 9 at 8:52 AM
Zogenix Provides Corporate Update and Reports Third Quarter Financial ResultsZogenix Provides Corporate Update and Reports Third Quarter Financial Results
finance.yahoo.com - November 8 at 5:14 PM
Zogenix to Present at Stifel 2018 Healthcare ConferenceZogenix to Present at Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 8:50 AM
Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8
finance.yahoo.com - November 1 at 8:32 AM
Zogenix Inc (NASDAQ:ZGNX): Is Breakeven Near?Zogenix Inc (NASDAQ:ZGNX): Is Breakeven Near?
finance.yahoo.com - October 19 at 4:46 PM
Zogenix Sees Hammer Chart Pattern: Time to Buy?Zogenix Sees Hammer Chart Pattern: Time to Buy?
www.zacks.com - October 18 at 8:56 AM
Noteworthy Monday Option Activity: ZGNX, NTNX, AFSINoteworthy Monday Option Activity: ZGNX, NTNX, AFSI
www.nasdaq.com - October 8 at 4:36 PM
Zogenix, Inc. (ZGNX) PT Raised to $93 at Leerink PartnersZogenix, Inc. (ZGNX) PT Raised to $93 at Leerink Partners
www.streetinsider.com - October 5 at 4:41 PM
ZGNX Crosses Below Key Moving Average LevelZGNX Crosses Below Key Moving Average Level
www.nasdaq.com - October 3 at 8:44 AM
Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug?Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug?
finance.yahoo.com - September 28 at 8:42 AM
Zogenix to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-OncologyZogenix to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
finance.yahoo.com - September 25 at 8:35 AM
Zogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish InitiationZogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish Initiation
finance.yahoo.com - September 14 at 4:41 PM
Northland Capital Markets Starts Zogenix, Inc. (ZGNX) at OutperformNorthland Capital Markets Starts Zogenix, Inc. (ZGNX) at Outperform
www.streetinsider.com - September 13 at 8:55 AM
Heres Why Zogenix Slipped 14.9% in AugustHere's Why Zogenix Slipped 14.9% in August
www.fool.com - September 10 at 3:13 PM
Dont Dread a Market Correction, Think Opportunistically InsteadDon't Dread a Market Correction, Think Opportunistically Instead
finance.yahoo.com - September 8 at 4:46 PM
Benzingas Top Upgrades, Downgrades For September 7, 2018Benzinga's Top Upgrades, Downgrades For September 7, 2018
www.benzinga.com - September 7 at 4:49 PM
Zogenixs ZX008 shows positive effect in mid-stage study in rare childhood epilepsy; shares up 5% premarketZogenix's ZX008 shows positive effect in mid-stage study in rare childhood epilepsy; shares up 5% premarket
seekingalpha.com - September 4 at 4:51 PM
Global Phase 3 Randomized, Controlled Study in LGS Currently Enrolling PatientsGlobal Phase 3 Randomized, Controlled Study in LGS Currently Enrolling Patients
globenewswire.com - September 4 at 8:57 AM
Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut SyndromeZogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome
finance.yahoo.com - September 4 at 8:57 AM
Todays Research Reports on Trending Tickers: CRISPR Therapeutics and ZogenixToday's Research Reports on Trending Tickers: CRISPR Therapeutics and Zogenix
finance.yahoo.com - September 4 at 8:57 AM
Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on EpileptologyZogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on Epileptology
finance.yahoo.com - August 30 at 8:57 AM
Zogenix Becomes Oversold (ZGNX)Zogenix Becomes Oversold (ZGNX)
www.nasdaq.com - August 29 at 9:00 AM
Edited Transcript of ZGNX earnings conference call or presentation 6-Aug-18 8:30pm GMTEdited Transcript of ZGNX earnings conference call or presentation 6-Aug-18 8:30pm GMT
finance.yahoo.com - August 16 at 4:59 PM
Zogenix Inc. (ZGNX) CEO Stephen Farr on Q2 2018 Results - Earnings Call TranscriptZogenix Inc. (ZGNX) CEO Stephen Farr on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 8:57 AM
Zogenix: 2Q Earnings SnapshotZogenix: 2Q Earnings Snapshot
finance.yahoo.com - August 7 at 8:57 AM
Zogenix Provides Corporate Update and Reports Second Quarter Financial ResultsZogenix Provides Corporate Update and Reports Second Quarter Financial Results
finance.yahoo.com - August 6 at 5:05 PM
Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6
finance.yahoo.com - August 1 at 9:46 AM
Tilray’s IPO is creating a buzz, but don’t overspend on marijuana stocksTilray’s IPO is creating a buzz, but don’t overspend on marijuana stocks
finance.yahoo.com - July 27 at 8:53 AM
3 Very Popular Marijuana Stocks on My "Do Not Buy" List3 Very Popular Marijuana Stocks on My "Do Not Buy" List
finance.yahoo.com - July 20 at 8:38 AM
This page was last updated on 12/9/2018 by MarketBeat.com Staff

Featured Article: What Are Treasury Bonds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel